Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $14

Author: Benzinga Newsdesk | April 10, 2024 03:27pm
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $19 to $14.

Posted In: SHC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist